BetterLife Pharma Inc. (CSE:BETR)
Canada · Delayed Price · Currency is CAD 0.0600
0.00 (0.00%)
Feb 9, 2026, 10:29 AM EST
BetterLife Pharma Market Cap
BetterLife Pharma has a market cap or net worth of CAD 8.85 million as of February 9, 2026. Its market cap has decreased by -49.69% in one year.
Market Cap
8.85M
Enterprise Value
12.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since October 4, 2010, BetterLife Pharma's market cap has decreased from 100.61M to 8.85M, a decrease of -91.20%. That is a compound annual growth rate of -14.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 8.85M | 31.55% |
| Dec 31, 2025 | 6.73M | -49.90% |
| Dec 31, 2024 | 13.43M | 83.04% |
| Dec 29, 2023 | 7.34M | -50.51% |
| Dec 30, 2022 | 14.82M | -19.16% |
| Dec 31, 2021 | 18.34M | -81.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lobe Sciences | 13.47M |
| Pharmala Biotech Holdings | 10.89M |
| Glow Lifetech | 9.98M |
| Cytophage Technologies | 9.81M |
| COSCIENS Biopharma | 8.72M |
| Marvel Biosciences | 8.12M |
| PharmaTher Holdings | 7.28M |
| BioVaxys Technology | 7.28M |